Decreased Expressions of STING but not IRF3 Molecules in Chronic HBV Infected Patients

Masoud Karimi-Googheri1, Hamid Daneshvar1, Mehdi Khaleghinia1

  • 1Department of Immunology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Abstract

Insights

Chronic HBV infection is linked to lower stimulator of interferon genes (STING) mRNA levels. This impaired STING expression may disrupt immune responses in patients with chronic hepatitis B.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • The stimulator of interferon genes (STING) pathway is crucial for innate immune responses against viral infections.
  • STING activation leads to interferon regulatory factor 3 (IRF3) activation upon detection of intracellular viral double-stranded DNA.
  • Chronic hepatitis B (CHB) infection is associated with immune dysregulation.

Purpose of the Study:

  • To investigate the mRNA expression levels of STING and its downstream target IRF3 in patients with CHB.
  • To explore the potential role of STING and IRF3 in the immune impairment observed in CHB.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were isolated from 60 CHB patients and 60 healthy controls.
  • Real-Time polymerase chain reaction (PCR) was employed to quantify STING and IRF3 mRNA levels.
  • Statistical analysis was performed using SPSS software version 18.

Main Results:

  • Significantly decreased STING mRNA levels were observed in CHB patients compared to healthy controls (P = 0.013).
  • No significant difference in IRF3 mRNA expression was found between CHB patients and healthy controls (P = 0.828).

Conclusions:

  • CHB patients exhibit reduced STING expression, suggesting a potential defect in innate immune sensing of HBV DNA.
  • Impaired STING signaling may contribute to the compromised immune responses characteristic of chronic hepatitis B.
  • These findings offer insights into the molecular mechanisms underlying immune evasion in CHB.